Business context and reporting period
This Form 10-Q covers the three months ended June 30, 2014, the first quarter of the company’s fiscal year. The filing identifies the registrant as Universal Security Instruments, Inc.; this differs from the company name in the request metadata. The company markets and distributes safety and security products, primarily manufactured by its 50%-owned Hong Kong joint venture (JV), which is accounted for using the equity method.
Financial results and liquidity
| Metric | Q1 2014 | Q1 2013 or comparison |
|---|---|---|
| Net sales | $2.514 million | $3.006 million; down 16.3% |
| Gross profit / margin | $611,488 / 24.3% | $749,324 / 24.9% |
| Operating loss | $737,967 | $467,056 |
| Net loss | $742,849; $0.32 per share | $19,530; $0.01 per share |
| Operating cash flow | $906,504 provided | $950,858 used |
| Cash and cash equivalents | $2.957 million at June 30 | $2.051 million at March 31, 2014 |
Current assets were $8.440 million and current liabilities were $1.004 million at June 30. The company reported no borrowings under its $1 million CIT factoring facility and no investing or financing cash flows in the quarter. The facility is secured by accounts receivable and inventory. A separate $25,000 long-term obligation relates to an uncertain tax position, penalties and imputed interest.
Operating cash inflow was driven mainly by lower inventory and prepaid expenses, reduced receivables and amounts due from the factor, and higher payables and accrued expenses; it occurred despite the net loss. The quarter-end balance sheet showed total assets of $22.815 million and shareholders’ equity of $21.786 million.
Material changes and management commentary
- Management attributed the company’s lower sales primarily to the timing of customer orders. Gross margin declined due to product mix. SG&A increased in dollars and as a share of sales, reflecting largely persistent costs against lower sales and higher audit-related professional fees.
- R&D expense rose to $161,964 from $126,636, principally for independent testing related to new product development. The company reported 13 patent applications, 10 granted, including six for new technologies and features; three applications remained pending.
- The JV’s quarterly sales fell to $3.665 million from $6.250 million, and it recorded a $121,206 net loss versus $527,078 net income. Its gross margin declined to 25.6% from 29.0%, attributed to labor costs and sales mix. USI’s equity in JV results shifted from $272,041 earnings to a $12,527 loss.
- The company generated additional net operating losses of $694,837. Tax benefits were fully reserved, so no income tax benefit was recognized in the quarter; deferred tax assets were subject to a full valuation allowance.
- Management said available factoring capacity, JV distributions and credit facilities were sufficient for liquidity needs and anticipated no change in its ability to maintain liquidity. No specific earnings or revenue guidance was provided.
Risks, contingencies and other notable items
Management concluded that disclosure controls and procedures were not effective at June 30, 2014 because a previously identified material weakness in financial reporting controls had not been determined to be remediated. Management stated that remediation steps were underway and believed the reported financial statements were fairly presented. Management, after consulting counsel, said material litigation losses were not reasonably likely and that legal matters were not expected to have a material adverse effect. The company generally provides product warranties of one to ten years and recorded a $25,000 reserve for claims beyond manufacturers’ one-year coverage.
The company was assessing the impact of ASU 2014-09, the new revenue recognition standard, which was scheduled to become effective January 1, 2017, with early adoption prohibited. Interim results are not necessarily indicative of full-year results.
Most important facts for investors to verify
- Confirm the registrant’s identity: the filing is for Universal Security Instruments, Inc., not Universal Safety Products, Inc.
- The cover page marks “No” for having filed all required Exchange Act reports during the preceding 12 months; verify the company’s filing-compliance status and the reason for this response.
- Seek details on the material weakness, remediation progress and any subsequent changes to control effectiveness.
- Monitor customer order timing, sales and product mix, and the JV’s performance, given its manufacturing role and sharp quarterly decline.
- Review the terms and continued availability of the CIT facility, reliance on working-capital movements for cash generation, and recoverability of deferred tax assets.